A male hormone-blocker currently used to treat prostate cancer may also benefit breast cancer patients.
The Scientist
Most Recent
A unique virus and the worm it infects turn up in an orchard outside of Paris.
In contrast to yesterday’s news about the success of an HPV vaccine program in Australia, an Indian trial of the vaccine is stoking unfounded fear among the public and exposing some questionable ethical standards
Drugmakers are teaming up to test the disease-fighting power of combination therapies earlier in the development cycle than ever before.
A former postdoctoral researcher at St. Jude Children’s Research Hospital fudged images published in two papers, one of which has since been retracted
An HPV vaccination program in Australia appears to have resulted in a drop in cervical lesions among young women
A snapshot of the most highly ranked articles in immunology and related areas, from Faculty of 1000
Proteins and nanoparticles that talk in order to more efficiently locate and treat tumors could reduce collateral damage to healthy tissues
Fourteen years after closure, an asbestos plant is still damaging DNA
Ovarian tumor cells use cellular movement proteins to penetrate protective cell layers surrounding new target tissues during metastasis
Follow The Scientist
Stay Connected with The Scientist
-
The Scientist Magazine
-
The Scientist Careers
-
Neuroscience Research Techniques
-
Genetic Research Techniques
-
Cell Culture Techniques
-
Microbiology and Immunology
-
Cancer Research and Technology
Current Issue
